AT279802B - Process for the preparation of new complexes with an antitussive effect - Google Patents

Process for the preparation of new complexes with an antitussive effect

Info

Publication number
AT279802B
AT279802B AT261667A AT261667A AT279802B AT 279802 B AT279802 B AT 279802B AT 261667 A AT261667 A AT 261667A AT 261667 A AT261667 A AT 261667A AT 279802 B AT279802 B AT 279802B
Authority
AT
Austria
Prior art keywords
preparation
antitussive effect
new complexes
complexes
new
Prior art date
Application number
AT261667A
Other languages
German (de)
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Application granted granted Critical
Publication of AT279802B publication Critical patent/AT279802B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT261667A 1966-03-18 1967-03-17 Process for the preparation of new complexes with an antitussive effect AT279802B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR54024A FR5227M (en) 1966-03-18 1966-03-18

Publications (1)

Publication Number Publication Date
AT279802B true AT279802B (en) 1970-03-25

Family

ID=8604122

Family Applications (1)

Application Number Title Priority Date Filing Date
AT261667A AT279802B (en) 1966-03-18 1967-03-17 Process for the preparation of new complexes with an antitussive effect

Country Status (6)

Country Link
AT (1) AT279802B (en)
BE (1) BE695604A (en)
DK (1) DK115144B (en)
FR (1) FR5227M (en)
GB (1) GB1183403A (en)
NL (1) NL6704037A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139881A1 (en) * 1983-09-16 1985-05-08 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171716B1 (en) * 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Process for the preparation of a complex of carrageenan and emepronium, doxycycline or propranolol
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
FR2640137A1 (en) * 1988-12-08 1990-06-15 Texinfine Sa SYSTEMS CONVEYING LIPOPHILIC ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING SAME
DE59107006D1 (en) * 1990-04-25 1996-01-18 Hoechst Ag Pharmacological preparation containing polyelectrolyte complexes in microparticulate form and at least one active ingredient.
IT1297461B1 (en) * 1997-10-29 1999-12-17 Ciocca Maurizio PREPARATION OF CONTROLLED RELEASE TABLETS BASED ON COMPLEXES BETWEEN CARRAGENANO AND SOLUBLE BASIC DRUGS
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE102004013637A1 (en) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Process for the preparation of CS particles and microcapsules using porous templates as well as CS particles and microcapsules
FR2906687A1 (en) * 2006-10-10 2008-04-11 Pierre Calleja Substrate for conservation and distribution of an active ingredient for aquatic animals, comprises an active ingredient, a hydrocolloid substance to inflate in contact with water, a palatable base, and a compressed metal base

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139881A1 (en) * 1983-09-16 1985-05-08 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents

Also Published As

Publication number Publication date
FR5227M (en) 1967-08-14
DK115144B (en) 1969-09-08
NL6704037A (en) 1967-09-19
BE695604A (en) 1967-09-18
GB1183403A (en) 1970-03-04

Similar Documents

Publication Publication Date Title
AT280996B (en) Process for the preparation of new 1-hydroxyphenyl-2-aminoalkanols
CH490319A (en) Process for the preparation of new amino-dihalogen-phenylethylamines
CH484049A (en) Process for the preparation of new hydroxycyclohexylamines
AT272343B (en) Process for the preparation of new 2-cycloalkylamino-oxazolines
AT267538B (en) Process for the preparation of new carbostyril derivatives
AT279802B (en) Process for the preparation of new complexes with an antitussive effect
AT275517B (en) Process for the preparation of new p-alkoxy-piperidine-amides
CH498130A (en) Process for the preparation of new pyridyl-tetrahydroisoquinolines
CH487887A (en) Process for the preparation of new 1-aryl-3-alkylaminopyrrolidines
AT261633B (en) Process for the preparation of new organotin complexes
AT272369B (en) Process for the preparation of new 6-amino-uracil-5-carbonamide-N-sulfonamides
AT291221B (en) Process for the preparation of new o-carboxyphenylamidines
CH482727A (en) Process for the preparation of new phosphinylimides
AT270653B (en) Process for the preparation of new 5-benzylpyrimidines
AT267712B (en) Process for the preparation of new aminodiphenyl-indolyl-methane dyes
AT283319B (en) Process for the preparation of new azidocinnamaldehydes
AT281797B (en) Process for the preparation of new dialkylaminoacylanilides
AT277186B (en) Process for the preparation of new Trihalogenäthylglycinaten
CH487114A (en) Process for the preparation of new 1-amino-3-aryloxypropane-2-ethers
CH497411A (en) Process for the preparation of new Homogonan derivatives
AT291448B (en) Process for the preparation of new 16-methyl-4-pregnen-3β-ol-20-ones
AT274779B (en) Process for the preparation of new 1-hydrazinoadamantanes
AT287676B (en) PROCESS FOR THE PREPARATION OF NEW 1-PHENOXY-2-AMINOALKANES
CH507223A (en) Process for the preparation of new 17-phenyloxyacetyloxysteroids
AT266141B (en) Process for the preparation of new Haxahydropyrimidine derivatives

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee